Enliven Therapeutics
Enliven Therapeutics is a clinical-stage biopharmaceutical company developing small molecule therapeutics using a precision medicine approach.
SCHEDULE 13G/AAug 6Latest SEC filing
Aug 5Latest story
August 2026
Enliven Therapeutics is a clinical-stage biopharmaceutical company developing small molecule therapeutics using a precision medicine approach.